首页> 外文期刊>Trends in Biotechnology >Domain antibodies: proteins for therapy.
【24h】

Domain antibodies: proteins for therapy.

机译:域抗体:用于治疗的蛋白质。

获取原文
获取原文并翻译 | 示例
       

摘要

Occurring naturally in 'heavy chain' immunoglobulins from camels, and now produced in fully human form, domain antibodies (dAbs) are the smallest known antigen-binding fragments of antibodies, ranging from 11 kDa to 15 kDa. dAbs are the robust variable regions of the heavy and light chains of immunoglobulins (V(H) and V(L) respectively). They are highly expressed in microbial cell culture, show favourable biophysical properties including solubility and temperature stability, and are well suited to selection and affinity maturation by in vitro selection systems such as phage display. dAbs are bioactive as monomers and, owing to their small size and inherent stability, can be formatted into larger molecules to create drugs with prolonged serum half-lives or other pharmacological activities.
机译:域抗体(dAb)是骆驼的“重链”免疫球蛋白中天然存在的,现在以完全人源的形式产生,是已知的最小的抗体抗原结合片段,范围从11 kDa到15 kDa。 dAb是免疫球蛋白重链和轻链的稳健可变区(分别为V(H)和V(L))。它们在微生物细胞培养物中高表达,显示出良好的生物物理特性(包括溶解度和温度稳定性),非常适合通过体外选择系统(例如噬菌体展示)进行选择和亲和力成熟。 dAb作为单体具有生物活性,由于其体积小和固有的稳定性,可以被制成更大的分子,从而产生具有延长的血清半衰期或其他药理活性的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号